Cite
Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies.
MLA
Vale, Thiago Cardoso, et al. “Morvan Syndrome as a Paraneoplastic Disorder of Thymoma with Anti-CASPR2 Antibodies.” Lancet, vol. 389, no. 10076, Apr. 2017, pp. 1367–68. EBSCOhost, https://doi.org/10.1016/S0140-6736(16)31459-3.
APA
Vale, T. C., Pedroso, J. L., Dutra, L. A., Azevedo, L., Pimentel Filho, L. H., Prado, L. B. F., Hoftberger, R., Prado, G. F., Barsottini, O. G., & Filho, L. H. P. (2017). Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies. Lancet, 389(10076), 1367–1368. https://doi.org/10.1016/S0140-6736(16)31459-3
Chicago
Vale, Thiago Cardoso, José Luiz Pedroso, Lívia Almeida Dutra, Lyamara Azevedo, Lucio Huebra Pimentel Filho, Lucila B. F. Prado, Romana Hoftberger, Gilmar F. Prado, Orlando G. Barsottini, and Lucio Huebra Pimentel Filho. 2017. “Morvan Syndrome as a Paraneoplastic Disorder of Thymoma with Anti-CASPR2 Antibodies.” Lancet 389 (10076): 1367–68. doi:10.1016/S0140-6736(16)31459-3.